首页|川崎病患儿凝血指标变化对发生静脉免疫球蛋白抵抗的影响

川崎病患儿凝血指标变化对发生静脉免疫球蛋白抵抗的影响

扫码查看
目的 探究凝血指标变化对川崎病(KD)患儿发生静脉免疫球蛋白抵抗的影响,为改善患儿预后提供经验。方法 本研究采用前瞻性研究方法,纳入2018年4月至2022年4月我院收治的180例KD患儿,所有患儿均行免疫球蛋白治疗。于治疗前检测患儿血清D-二聚体(D-D)、凝血四项[活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、凝血酶原时间(PT)、纤维蛋白原(FIB)]水平,设计患儿基线资料调查表,记录研究所需资料。治疗后统计KD患儿静脉免疫球蛋白抵抗的发生情况,依据免疫球蛋白抵抗的发生情况分为发生组、未发生组。将可能的因素纳入,重点分析凝血指标变化对患儿发生静脉免疫球蛋白抵抗的影响,探究其对KD患儿发生静脉免疫球蛋白抵抗的预测价值。结果 本研究180例行免疫球蛋白治疗的KD患儿中发生静脉免疫球蛋白抵抗41例,占比22。78%(41/180)。发生组患者治疗前血清D-D、FIB、白细胞介素-6(IL-6)、中性粒细胞百分比(NEUT%)均高于未发生组(P<0。05);两组APTT、TT、PT及其他基线资料比较(P>0。05)。经Logistic回归分析结果显示,治疗前血清D-D、FIB、IL-6、NEUT%高是KD患儿发生静脉免疫球蛋白抵抗的危险因素(OR>1,P<0。05)。绘制受试者工作特征(ROC)曲线,结果显示,血清D-D、血清FIB及联合预测KD患儿发生静脉免疫球蛋白抵抗的曲线下面积(AUC)均≥0。07,其中联合预测价值最高。结论 治疗前血清D-D、FIB水平高是KD患儿并发静脉免疫球蛋白抵抗的危险因素,联合检测二者水平可用于预测评估患儿静脉免疫球蛋白抵抗发生风险。
Effect of Coagulation Index Changes on the Occurrence of Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease
Objective To explore the influence of coagulation index changes on intravenous immunoglobulin resistance in children with Kawasaki disease(KD),and to provide experience for improving the prognosis of children.Methods A prospective study was conducted in this study.180 children with KD who were admitted to our Hospital from April 2018 to April 2022 were included.All children were treated with immunoglobulin.Before treatment,the levels of serum D-dimer(D-D)and blood coagulation(activated partial thromboplastin time(APTT),thrombin time(TT),prothrombin time(PT)and fibrinogen(FIB))were measured,and the baseline data questionnaire was designed to record the data needed for the study.After treatment,the incidence of intravenous immunoglobulin resistance in KD children was counted and divided into occurrence group and non occurrence group according to the occurrence of immunoglobulin resistance.The possible factors were included,and the impact of changes in coagulation indexes on the occurrence of venous immunoglobulin resistance in children was analyzed,to explore its predictive value for the occurrence of venous immunoglobulin resistance in children with KD.Results Among 180 cases of KD treated with immunoglobulin,41 cases(22.78%)developed venous immunoglobulin resistance.The serum D-D,FIB,interleukin-6(IL-6)and percentage of neutrophils(NEUT%)in the patients in the occurrence group were higher than those in the non occurrence group before treatment(P<0.05).Comparison of APTT,TT,PT and other baseline data between the two groups(P>0.05).Logistic regression analysis showed that high levels of serum D-D,FIB,IL-6 and NEUT%before treatment were the risk factors for intravenous immunoglobulin resistance in KD children(OR>1,P<0.05).The ROC curve was drawn.The results showed that the area under the curve(AUC)of serum D-D,serum FIB and combined prediction of venous immunoglobulin resistance in KD children were≥0.07,and the combined prediction value was the highest.Conclusion The high level of serum D-D and FIB before treatment is a risk factor for KD children with venous immunoglobulin resistance.The combined detection of the two levels can be used to predict and evaluate the risk of venous immunoglobulin resistance in children with KD.

Kawasaki DiseaseImmunoglobulin ResistanceCoagulation FunctionD-dimerFibrinogen

张玉芳、郭继伟

展开 >

太康县人民医院儿科(河南太康 461400)

川崎病 免疫球蛋白抵抗 凝血功能 D-二聚体 纤维蛋白原

2025

罕少疾病杂志
深圳市卫生局

罕少疾病杂志

影响因子:0.583
ISSN:1009-3257
年,卷(期):2025.32(1)